Semaglutide belongs to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs. It mimics the GLP-1 hormone, released in the gut in response to eating. One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood sugar (glucose). For that reason, health care providers have safely used semaglutide for more than 15 years to treat Type 2 diabetes. But GLP-1 in higher amounts also interacts with the parts of the brain that suppress your appetite and signal you to feel full.
 
Prism Med Spa supports this medical weight loss program by using it in conjunction with diet and exercise, where it can cause significant weight loss — and a reduced risk of cancer, diabetes and heart disease — in people who are obese or overweight 2 .

Semaglutide is only approved for weight loss. The typical dose for weight loss is 2.4 milligrams, 

administered weekly as subcutaneous (under the skin) self-injections 2 .Depending on the weight loss goal, that dose is increased monthly until your goal is achieved.

Common side effects of Semaglutide can be Diarrhea, Nausea, Constipation, Elevated serum lipase, Elevated serum amylase, Vomiting, Acute abdominal pain, Fatigue, Biliary calculus, Gastroesophageal reflux disease, Dyspepsia, Flatulence, Eructation, Tachycardia and Hypoglycemic disorder 1 .